Voluntary patient assistance programs: additional federal oversight unwarranted.
The Partnership for Prescription Assistance, which links struggling patients to more than 475 patient assistance programs, provides a vital safety net for millions of uninsured Americans. Proposing unwarranted government regulation during these uncertain economic times could cast a chill nationwide on other philanthropic efforts.
Pharmaceutical Research and Manufacturers of America (PhRMA) in Washington, DC, USA. ken.johnson@phrma.org
Ken
K
Johnson
D026686:Beneficence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions / Q000191:economics*; D005380:Financing, Government / Q000191:economics / Q000331:legislation & jurisprudence*; D005381:Financing, Organized / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics / Q000331:legislation & jurisprudence*; D008483:Medical Assistance / Q000191:economics / Q000331:legislation & jurisprudence*; D017664:Uncompensated Care / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States; D014837:Voluntary Health Agencies / Q000191:economics / Q000331:legislation & jurisprudence*